Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Testosterone tridecanoate by Lipocine for Hepatic Encephalopathy: Likelihood of Approval
Testosterone tridecanoate is under clinical development by Lipocine and currently in Phase II for Hepatic Encephalopathy. According to GlobalData, Phase...
Brexanolone by Lipocine for Post Partum Depression (Maternal Depression / Postnatal Depression): Likelihood of Approval
Brexanolone is under clinical development by Lipocine and currently in Phase III for Post Partum Depression (Maternal Depression / Postnatal...
Testosterone tridecanoate by Lipocine for Sarcopenia: Likelihood of Approval
Testosterone tridecanoate is under clinical development by Lipocine and currently in Phase II for Sarcopenia. According to GlobalData, Phase II...
LPCN-2203 by Lipocine for Essential Tremor: Likelihood of Approval
LPCN-2203 is under clinical development by Lipocine and currently in Phase I for Essential Tremor. According to GlobalData, Phase I...
Testosterone tridecanoate by Lipocine for Decompensated Cirrhosis: Likelihood of Approval
Testosterone tridecanoate is under clinical development by Lipocine and currently in Phase II for Decompensated Cirrhosis. According to GlobalData, Phase...
LPCN-2401 by Lipocine for Obesity: Likelihood of Approval
LPCN-2401 is under clinical development by Lipocine and currently in Phase II for Obesity. According to GlobalData, Phase II drugs...